Invesco’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.9M | Sell |
243,063
-45,076
| -16% | -$1.28M | ﹤0.01% | 2011 |
|
|
2025
Q1 | $8.51M | Buy |
288,139
+193,376
| +204% | +$5.71M | ﹤0.01% | 1870 |
|
|
2024
Q4 | $2.76M | Sell |
94,763
-215,593
| -69% | -$6.27M | ﹤0.01% | 2491 |
|
|
2024
Q3 | $14.3M | Sell |
310,356
-39,999
| -11% | -$1.84M | ﹤0.01% | 1648 |
|
|
2024
Q2 | $14.3M | Sell |
350,355
-22,961
| -6% | -$938K | ﹤0.01% | 1600 |
|
|
2024
Q1 | $9.53M | Buy |
373,316
+245,444
| +192% | +$6.26M | ﹤0.01% | 1841 |
|
|
2023
Q4 | $1.16M | Sell |
127,872
-10,128
| -7% | -$91.7K | ﹤0.01% | 2821 |
|
|
2023
Q3 | $880K | Buy |
138,000
+44,653
| +48% | +$285K | ﹤0.01% | 2916 |
|
|
2023
Q2 | $1.04M | Sell |
93,347
-73,436
| -44% | -$814K | ﹤0.01% | 2866 |
|
|
2023
Q1 | $2.56M | Buy |
166,783
+97,862
| +142% | +$1.5M | ﹤0.01% | 2534 |
|
|
2022
Q4 | $1.53M | Sell |
68,921
-78,655
| -53% | -$1.75M | ﹤0.01% | 2735 |
|
|
2022
Q3 | $2.41M | Buy |
147,576
+112,540
| +321% | +$1.84M | ﹤0.01% | 2550 |
|
|
2022
Q2 | $509K | Buy |
35,036
+4,799
| +16% | +$69.7K | ﹤0.01% | 3295 |
|
|
2022
Q1 | $558K | Buy |
30,237
+15,442
| +104% | +$285K | ﹤0.01% | 3302 |
|
|
2021
Q4 | $351K | Buy |
14,795
+533
| +4% | +$12.6K | ﹤0.01% | 3510 |
|
|
2021
Q3 | $352K | Buy |
14,262
+2,966
| +26% | +$73.2K | ﹤0.01% | 3556 |
|
|
2021
Q2 | $279K | Buy |
+11,296
| New | +$279K | ﹤0.01% | 3630 |
|